Subject: Letter to GP requesting reconsideration of refusal to provide blood test monitoring
(Your Name)
(Your Address)
(City, Postal Code)
(Your Phone Number)
(Your Email)
(Date)
Dr (GP’s Name)
(Practice Name)
(Practice Address)
(City, Postal Code)
Dear Dr (GP’s Name),
Re: Request for reconsideration of refusal of blood test monitoring
My NHS Number: [NHS Number]
I am writing to formally request that you reconsider the recent decision made by [NAME] on [DATE] to refuse blood test monitoring whilst I am receiving gender affirming hormone replacement therapy (HR). [Attach a copy of the decision letter, if available].
My request was reasonable. This monitoring is medically necessary and falls within the standard of care for patients receiving HR.
Clinical rationale for monitoring
Regular blood test monitoring during HR is recommended by established clinical guidelines, including:
- Endocrine Society Clinical Practice Guidelines for transgender healthcare
- World Professional Association for Transgender Health (WPATH) Standards of Care
- NHS England Service Specification for Gender Identity Services
The monitoring typically includes assessment of:
- Hormone levels to ensure therapeutic ranges and treatment effectiveness
- Liver function tests to monitor for potential hepatic effects, and kidney function U+E’s including potassium
- Lipid profiles to assess cardiovascular risk factors
- Full blood count and metabolic panels for general health monitoring
My current situation
[Include relevant details about your treatment, such as:]
- I am currently administered [specify hormones/medications] prescribed by [specialist/clinic name] OR [I am self-medicating]
- I have been taking [name of prescription] since [date]
- My latest blood tests were conducted on [date]. A copy of them should be in my medical records. I understand that they showed [brief summary if relevant]
Request for shared care
I understand that [a specialist service can initiate HR/ I am self-medicating], but ongoing monitoring can appropriately be provided in primary care as (part of a shared care arrangement OR harm reduction (if self-medicating)).
This approach has the following benefits:
- Ensures continuity of care and early detection of any complications
- Follows established protocols for monitoring patients on long-term medication
- Provides cost-effective care delivery
- Maintains the therapeutic relationship with my GP
Patient safety considerations
Without appropriate monitoring, there are potential risks, including undetected adverse effects on liver function, cardiovascular health, or hormone imbalances. Regular blood tests represent a standard safety measure that helps ensure the therapy remains both safe and effective.
I would be grateful if you could reconsider your decision and arrange the necessary blood tests. I am happy to discuss the monitoring schedule and specific tests required, and can provide additional clinical information from my prescribing clinician if needed.
[Please note I consider myself to be protected by the protected characteristic of ‘gender reassignment’ under the Equality Act 2010. All my rights are reserved in this regard.]
I look forward to your response and to continuing to work together to ensure my healthcare needs are met appropriately.
Thank you for your time and consideration.
Yours sincerely,
(Your Signature)
(Your Printed Name)
(Your Date of Birth)
(Your NHS Number)